PT Mitra Keluarga Karyasehat (MIKA) investor relations material

Executive summary

• Leading Indonesian hospital group with over 35 years of operational excellence and a strong presence in Greater Jakarta and Surabaya.

• Consistently profitable, with rapid ramp-up of new hospitals and high doctor retention.

• Focused on comprehensive patient care, high-complexity services, and continuous facility modernization.

• Recognized for market dominance, governance, and elite patient outcomes.

• Net revenue for Q1 2026 reached Rp1.36 trillion, up from Rp1.27 trillion year-over-year, with net profit rising to Rp345.0 billion from Rp332.2 billion.

Financial highlights

• Revenue for 3M26/Q1 2026 reached IDR 1.36T, up 6.6% year-over-year; net income rose 3.8% to IDR 345B.

• EBITDA margin remained strong at 37.6%, with ROIC at 23.7%.

• Private revenue contribution increased to 89% in 3M26, reflecting a strategic shift.

• Revenue per inpatient day grew 8.1% and per outpatient visit by 11.6% year-over-year.

• Cash and cash equivalents at period end were IDR 2.08T, up 36.6% from prior year.

Outlook and guidance

• Pipeline includes seven new hospitals with up to 1,400 additional beds by Q4 2026.

• Continued expansion in high-complexity specialties and integrated oncology services.

• Ongoing modernization to elevate patient experience and service quality.

• Management continues to focus on operational efficiency and expansion of healthcare services.